Clinical Trial Update: Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Polidocanol Endovenous Microfoam to vehicle for treating saphenofemoral junction incompetence in varicose veins; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicose Veins

Drugs mentioned

• Polidocanol Endovenous Microfoam (polidocanol endovenous microfoam)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Varicose Veins | Phase 3 | Status: COMPLETED | Results posted: 2014-04-02